InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc.

CLDX Clue Score15
United States Fiscal year ends December CIK 0000744218 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Anthony S Marucci
11 Nov 2024
President & CEO
Buy
11,500
$26.82
$308.43K
Freddy A. Jimenez
11 Aug 2021
SVP & General Counsel
Buy
430
$46.28
$19.90K
Diane C. Young
11 Jun 2020
SVP, Chief Medical Officer
Buy
2,115
$4.73
$10.00K
Sarah Cavanaugh
10 Jun 2020
SVP of Corp Affairs & Admin.
Buy
1,050
$4.83
$5.07K
Anthony S Marucci
9 Jun 2020
President & CEO
Buy
15,000
$3.06
$45.90K
Tibor Keler
9 Jun 2020
Executive VP & CSO
Buy
5,000
$2.99
$14.95K
James J Marino
9 Jun 2020
Director
Buy
8,305
$3.00
$24.92K
Samuel Bates Martin
9 Jun 2020
SVP and CFO
Buy
9,750
$3.05
$29.74K
Margo Heath-Chiozzi
9 Jun 2020
SVP of Regulatory Affairs
Buy
1,000
$3.01
$3.01K
James J Marino
24 Aug 2018
Director
Buy
40,000
$0.48
$19.20K
Tibor Keler
15 Jun 2018
Executive VP & CSO
Buy
16,500
$0.59
$9.78K
Show all 65 transactions →

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 40
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 1,008,121
History held since 8 Jan 2007